These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 19289925)
1. Adjuvant treatment with vindesine for metastatic melanoma: in response to the study of Eigentler et al. (2008). Retsas S; Quigley M; Pectasides D; Henry K Melanoma Res; 2009 Apr; 19(2):123-4. PubMed ID: 19289925 [No Abstract] [Full Text] [Related]
2. Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group. Eigentler TK; Radny P; Hauschild A; Gutzmer R; Linse R; Pföhler C; Wagner SN; Schadendorf D; Ellwanger U; Garbe C; Melanoma Res; 2008 Oct; 18(5):353-8. PubMed ID: 18781134 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy of malignant melanoma: is there a choice? Retsas S Crit Rev Oncol Hematol; 2001 Nov; 40(2):187-93. PubMed ID: 11682325 [TBL] [Abstract][Full Text] [Related]
4. Inefficacy of vindesine monotherapy in advanced stage IV malignant melanoma patients previously treated with other chemotherapeutic agents. Emmert S; Zutt M; Haenssle H; Neumann C; Kretschmer L Melanoma Res; 2003 Jun; 13(3):299-302. PubMed ID: 12777986 [TBL] [Abstract][Full Text] [Related]
6. Melanoma and immunotherapy. Eggermont AM; Schadendorf D Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602 [TBL] [Abstract][Full Text] [Related]
7. Surgical management of melanoma. Wargo JA; Tanabe K Hematol Oncol Clin North Am; 2009 Jun; 23(3):565-81, x. PubMed ID: 19464603 [TBL] [Abstract][Full Text] [Related]
8. The role of vindesine in oncology--recommendations after 10 years' experience. Dancey J; Steward WP Anticancer Drugs; 1995 Oct; 6(5):625-36. PubMed ID: 8845472 [TBL] [Abstract][Full Text] [Related]
9. The history and future of chemotherapy for melanoma. Yang AS; Chapman PB Hematol Oncol Clin North Am; 2009 Jun; 23(3):583-97, x. PubMed ID: 19464604 [TBL] [Abstract][Full Text] [Related]
10. A randomised trial of vindesine plus interferon-alpha 2b compared with interferon-alpha 2b or vindesine alone in the treatment of advanced malignant melanoma. Vorobiof DA; Bezwoda WR Eur J Cancer; 1994; 30A(6):797-800. PubMed ID: 7917540 [TBL] [Abstract][Full Text] [Related]
19. Is there any reason to delay introduction of tumor necrosis factor in the management of in-transit metastasis of unresectable melanoma? Garrido-Laguna I; Ponz M; Espinós J J Clin Oncol; 2007 Mar; 25(9):1149; author reply 1149-51. PubMed ID: 17369585 [No Abstract] [Full Text] [Related]
20. The comparative clinical pharmacology of vincristine and vindesine: does vindesine offer any advantage in clinical use? Joel S Cancer Treat Rev; 1996 Nov; 21(6):513-25. PubMed ID: 8599802 [No Abstract] [Full Text] [Related] [Next] [New Search]